Post by Drees & Sommer China

🌐 Bridging Green Innovation: Drees & Sommer Joins the May 2026 German Bio-Pharma Delegation to China In May 2026, organized by the China International Investment Promotion Agency (Germany), the "2026 German Bio-Pharma Expert and Enterprise Delegation" embarked on an impactful journey across China's leading pharmaceutical clusters in Suzhou, Nanjing, Hainan, and Nantong. At each stop, the delegation received a warm welcome from local governments, industrial parks, and leading enterprises. As a globally renowned champion in building engineering, and project consulting, Drees & Sommer throughout the entire visit. 💡 A Shared Mission: Sino-German Collaboration Under Global Carbon-Neutrality Goals Against the backdrop of global pharmaceutical supply chain restructuring and the pressing need for green transformation, the complementarity between China and Germany in the life sciences has never been more pronounced. Under the shared guidance of global "Dual Carbon" targets, transitioning the energy-intensive pharmaceutical industry into a green model became the underlying theme of this exchange. 📍 Drees & Sommer's Expert Insight: The Critical Role of Decarbonization in Life Sciences Facilities The life sciences industry is traditionally a high-energy-consuming and high-emission sector. Maintaining strict temperature, humidity, and high-frequency air changes in cleanrooms results in a carbon footprint far exceeding that of conventional industrial facilities. During the seminars, Drees & Sommer highlighted that throughout the entire lifecycle of a facility (from conceptual design and construction to operation and maintenance), implementing digital twins, innovative energy recovery systems, and green building standards (such as DGNB, LEED, and China’s Three-Star rating) allows pharma companies to lower carbon emissions and operational costs drastically—all while maintaining the highest GMP compliance. 👏 Our Vision: Serving as the Ultimate Bridge for Sino-German Life Sciences Success Rooted in Germany with years of deep localization in China, Drees & Sommer naturally embodies a dual cultural and technical DNA. 📍 For German Enterprises: We seamlessly bridge Germany’s rigorous engineering standards with China’s rapid construction speed and complex regulatory frameworks, ensuring German technologies and production lines achieve a safe, compliant, and "soft landing" in China. 📍 For Chinese Enterprises: We introduce cutting-edge European sustainability concepts and "Blue Building" philosophies, empowering domestic pharma companies to build future-ready, low-carbon facilities that meet global standards for international expansion. Taking this May 2026 delegation as a new milestone, Drees & Sommer will continue to work hand-in-hand with CIPA and all industry partners. We are not just witnesses to Sino-German business trust; we are dedicated to being the premier builders of a net-zero future for the life sciences industry.